{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T13:50:05Z","timestamp":1722261005242},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Community Health"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10900-013-9704-y","type":"journal-article","created":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T01:43:33Z","timestamp":1369964613000},"page":"941-950","source":"Crossref","is-referenced-by-count":12,"title":["Latent Tuberculosis Infection: Screening and Treatment in an Urban Setting"],"prefix":"10.1007","volume":"38","author":[{"given":"Jamie P.","family":"Morano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary R.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei","family":"Zelenev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Douglas","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,1]]},"reference":[{"key":"9704_CR1","volume-title":"Global tuberculosis report 2012: Tuberculosis executive summary","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. (2012). Global tuberculosis report 2012: Tuberculosis executive summary. Geneva: Switzerland."},{"issue":"11","key":"9704_CR2","first-page":"181","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. (2012). Trends in tuberculosis\u2014United States, 2011. MMWR, 61(11), 181\u2013189.","journal-title":"MMWR"},{"key":"9704_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2307\/2669318","volume":"44","author":"S Jackman","year":"2000","unstructured":"Jackman, S. (2000). Estimation and inference via Bayesian simulation: An introduction to Markov Chain Monte Carlo. American Journal of Political Science, 44, 375\u2013404.","journal-title":"American Journal of Political Science"},{"issue":"9","key":"9704_CR4","first-page":"1104","volume":"14","author":"Y Hirsch-Moverman","year":"2010","unstructured":"Hirsch-Moverman, Y., Bethel, J., Colson, P. W., Franks, J., & El-Sadr, W. (2010). Predictors of latent tuberculosis infection treatment completion in the United States: An inner city experience. The International Journal of Tuberculosis and Lung Disease, 14(9), 1104\u20131111.","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"35","key":"9704_CR5","first-page":"495","volume":"2010","author":"C Lazar","year":"2008","unstructured":"Lazar, C., Sosa, L., & Lobato, M. (2008). Practices and policies of providers testing school-aged children for tuberculosis, Connecticut. Journal of Community Health, 2010(35), 495\u2013499.","journal-title":"Journal of Community Health"},{"issue":"8","key":"9704_CR6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.5588\/ijtld.10.0518","volume":"15","author":"A Guh","year":"2011","unstructured":"Guh, A., Sosa, L., Hadler, J. L., & Lobato, M. N. (2011). Missed opportunities to prevent tuberculosis in foreign-born persons, Connecticut, 2005\u20132008. The International Journal of Tuberculosis and Lung Disease, 15(8), 1044\u20131049.","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"6","key":"9704_CR7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/521166","volume":"45","author":"FL Altice","year":"2007","unstructured":"Altice, F. L., Maru, D. S., Bruce, R. D., Springer, S. A., & Friedland, G. H. (2007). Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial. Clinical Infectious Diseases, 45(6), 770\u2013778.","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"9704_CR8","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/QAD.0b013e32811ebf68","volume":"21","author":"GE Macalino","year":"2007","unstructured":"Macalino, G. E., Hogan, J. W., Mitty, J. A., Bazerman, L. B., Delong, A. K., Loewenthal, H., et al. (2007). A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS, 21(11), 1473\u20131477.","journal-title":"AIDS"},{"issue":"2\u20133","key":"9704_CR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.drugalcdep.2010.07.025","volume":"113","author":"KM Berg","year":"2011","unstructured":"Berg, K. M., Litwin, A., Li, X., Heo, M., & Arnsten, J. H. (2011). Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial. Drug and Alcohol Dependence, 113(2\u20133), 192\u2013199.","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"9704_CR10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/00952990.2011.643975","volume":"38","author":"R Bruce","year":"2012","unstructured":"Bruce, R., Eiserman, J., Acosta, A., Gote, C., Lim, J., & Altice, F. (2012). Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance treatment program: Implications for program replication. American Journal of Drug and Alcohol Abuse, 38(3), 206\u2013212.","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"9704_CR11","volume-title":"Applied missing data analysis","author":"C Enders","year":"2010","unstructured":"Enders, C. (2010). Applied missing data analysis. New York: Guilford Press."},{"issue":"5","key":"9704_CR12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1525-1446.2002.19504.x","volume":"19","author":"J Liebman","year":"2002","unstructured":"Liebman, J., Lamberti, P., & Altice, F. (2002). Effectiveness of a mobile medical van in providing screening services for STDs and HIV. Public Health Nursing, 19(5), 345\u2013353.","journal-title":"Public Health Nursing"},{"issue":"1","key":"9704_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jurban\/jti016","volume":"82","author":"FL Altice","year":"2005","unstructured":"Altice, F. L., Bruce, R. D., Walton, M. R., & Buitrago, M. I. (2005). Adherence to hepatitis B virus vaccination at syringe exchange sites. Journal of Urban Health, 82(1), 151\u2013161.","journal-title":"Journal of Urban Health"},{"issue":"S1","key":"9704_CR14","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/QAI.0b013e31820a8226","volume":"56","author":"L Weiss","year":"2011","unstructured":"Weiss, L., Netherland, J., Egan, J. E., Flanigan, T. P., Fiellin, D. A., Finkelstein, R., et al. (2011). Integration of buprenorphine\/naloxone treatment into HIV clinical care: Lessons from the BHIVES collaborative. Journal of Acquired Immune Deficiency Syndromes, 56(S1), S68\u2013S75.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"S1","key":"9704_CR15","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","volume":"56","author":"FL Altice","year":"2011","unstructured":"Altice, F. L., Bruce, R. D., Lucas, G. M., Lum, P. J., Korthuis, P. T., Flanigan, T. P., et al. (2011). HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: Results from a multisite study. Journal of Acquired Immune Deficiency Syndromes, 56(S1), S22\u2013S32.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"9704_CR16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11524-010-9438-4","volume":"87","author":"SA Springer","year":"2010","unstructured":"Springer, S. A., Chen, S., & Altice, F. L. (2010). Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: The impact of buprenorphine treatment. Journal of Urban Health, 87(4), 592\u2013602.","journal-title":"Journal of Urban Health"},{"issue":"S4","key":"9704_CR17","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1086\/508183","volume":"43","author":"LE Sullivan","year":"2006","unstructured":"Sullivan, L. E., Bruce, R. D., Altice, F. L., Haltiwanger, D., Lucas, G. M., Eldred, L., et al. (2006). Initial strategies for integrating buprenorphine into HIV care settings in the United States. Clinical Infectious Diseases, 43(S4), S191\u2013S196.","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"9704_CR18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/00952990903447741","volume":"35","author":"RK Schwarz","year":"2009","unstructured":"Schwarz, R. K., Bruce, R. D., Ball, S. A., Herme, M., & Altice, F. L. (2009). Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: Policy implications for tuberculosis screening. American Journal of Drug and Alcohol Abuse, 35(6), 439\u2013444.","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"2","key":"9704_CR19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/QAI.0b013e3181938e7e","volume":"50","author":"DS Maru","year":"2009","unstructured":"Maru, D. S., Bruce, R. D., Walton, M., Springer, S. A., & Altice, F. L. (2009). Persistence of virological benefits following directly administered antiretroviral therapy among drug users: Results from a randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes, 50(2), 176\u2013181.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"2","key":"9704_CR20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10461-007-9336-2","volume":"12","author":"DS Maru","year":"2008","unstructured":"Maru, D. S., Bruce, R. D., Walton, M., Mezger, J. A., Springer, S. A., Shield, D., et al. (2008). Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy. AIDS and Behavior, 12(2), 284\u2013293.","journal-title":"AIDS and Behavior"},{"issue":"S5","key":"9704_CR21","doi-asserted-by":"crossref","first-page":"S376","DOI":"10.1086\/421400","volume":"38","author":"FL Altice","year":"2004","unstructured":"Altice, F. L., Mezger, J. A., Hodges, J., Bruce, R. D., Marinovich, A., Walton, M., et al. (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication. Clinical Infectious Diseases, 38(S5), S376\u2013S387.","journal-title":"Clinical Infectious Diseases"},{"issue":"S1","key":"9704_CR22","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/01.qai.0000248338.74943.85","volume":"43","author":"D Smith-Rohrberg","year":"2006","unstructured":"Smith-Rohrberg, D., Mezger, J., Walton, M., Bruce, R. D., & Altice, F. L. (2006). Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users. Journal of Acquired Immune Deficiency Syndromes, 43(S1), S48\u2013S53.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"9704_CR23","doi-asserted-by":"crossref","unstructured":"Saber-Tehrani A. S., Springer S. A., Qiu J., Herme M., Wickersham J., & Altice F. L. (2012). Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community\u2014a potential conduit to improved HIV treatment outcomes. Contemporary Clinical Trials, 33(2), 436\u2013444.","DOI":"10.1016\/j.cct.2011.11.002"},{"key":"9704_CR24","volume-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventative therapy for people living with HIV in resource-constrained settings","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. (2011). Guidelines for intensified tuberculosis case-finding and isoniazid preventative therapy for people living with HIV in resource-constrained settings. Geneva: Switzerland."},{"key":"9704_CR25","unstructured":"World Health Organization. (2011). Tuberculosis country profiles. http:\/\/www.who.int\/tb\/country\/data\/profiles\/en\/index.html . Accessed Nov 2012."},{"key":"9704_CR26","unstructured":"Stop TB Partnership. (2011). Global TB incidence rates. http:\/\/www.stoptb.org\/assets\/images\/countries\/map_incidence.jpg . Accessed Nov 2012."},{"key":"9704_CR27","volume-title":"Stata statistical software","author":"StataCorp","year":"2011","unstructured":"StataCorp. (2011). Stata statistical software. College Station, TX: StataCorp LP."},{"issue":"3","key":"9704_CR28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0740-5472(98)00033-6","volume":"16","author":"N Salomon","year":"1999","unstructured":"Salomon, N., Perlman, D., Friedmann, P., Perkins, M. P., Ziluck, V., Des Jarlais, D., et al. (1999). Knowledge of tuberculosis among drug users relationship to return rates for tuberculosis screening at a syringe exchange. Journal of Substance Abuse Treatment, 16(3), 229\u2013235.","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"9704_CR29","first-page":"47","volume":"4","author":"N Salomon","year":"2000","unstructured":"Salomon, N., Perlman, D., Friedmann, P., Ziluck, V., & Des Jarlais, D. (2000). Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program. The International Journal of Tuberculosis and Lung Disease, 4(1), 47\u201354.","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"23","key":"9704_CR30","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling, T. R., Villarino, M. E., Borisov, A. S., Shang, N., Gordin, F., Bliven-Sizemore, E., et al. (2011). Three months of rifapentine and isoniazid for latent tuberculosis infection. The New England Journal of Medicine, 365(23), 2155\u20132166.","journal-title":"The New England Journal of Medicine"}],"container-title":["Journal of Community Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-013-9704-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10900-013-9704-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-013-9704-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:09:34Z","timestamp":1559264974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10900-013-9704-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,1]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9704"],"URL":"https:\/\/doi.org\/10.1007\/s10900-013-9704-y","relation":{},"ISSN":["0094-5145","1573-3610"],"issn-type":[{"value":"0094-5145","type":"print"},{"value":"1573-3610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,1]]}}}